‘Engage the World’: examining conflicts of engagement in public museums

Public engagement has become a central theme in the mission statements of many cultural institutions, and in scholarly research into museums and heritage. Engagement has emerged as the go-to-it-word for generating, improving or repairing relations between museums and society at large. But engagement is frequently an unexamined term that might embed assumptions and ignore power relationships. This article describes and examines the implications of conflicting and misleading uses of ‘engagement’ in relation to institutional dealings with contested questions about culture and heritage. It considers the development of an exhibition on the Dead Sea Scrolls by the Royal Ontario Museum, Toronto in 2009 within the new institutional goal to ‘Engage the World’. The chapter analyses the motivations, processes and decisions deployed by management and staff to ‘Engage the World’, and the degree to which the museum was able to re-think its strategies of public engagement, especially in relation to subjects,issues and publics that were more controversial in nature

A Randomized Controlled Trial of a Faith-Placed, Lay Health Advisor Delivered Smoking Cessation Intervention for Rural Residents

Introduction. Rural US residents smoke at higher rates than urban or suburban residents. We report results from a community-based smoking cessation intervention in Appalachian Kentucky. Study design. Single-blind, group-randomized trial with outcome measurements at baseline, 17 weeks and 43 weeks. Setting/participants. This faith-placed CBPR project was located in six counties of rural Appalachian Kentucky. A total of 590 individual participants clustered in 28 churches were enrolled in the study. Intervention. Local lay health advisors delivered the 12-week Cooper/Clayton Method to Stop Smoking program, leveraging sociocultural factors to improve the cultural salience of the program for Appalachian smokers. Participants met with an interventionist for one 90 min group session once per week incorporating didactic information, group discussion, and nicotine replacement therapy. Main outcome measures. The primary outcome was self-reported smoking status. Secondary outcomes included Fagerström nicotine dependence, self-efficacy, and decisional balance. Results. With post-intervention data from 92% of participants, those in intervention group churches (N = 383) had 13.6 times higher odds of reporting quitting smoking one month post-intervention than participants in attention control group churches (N = 154, p \u3c 0.0001). In addition, although only 3.2% of attention control group participants reported quitting during the control period, 15.4% of attention control participants reported quitting smoking after receiving the intervention. A significant dose effect of the 12-session Cooper/Clayton Method was detected: for each additional session completed, the odds of quitting smoking increased by 26%. Conclusions. The Cooper/Clayton Method, delivered in rural Appalachian churches by lay health advisors, has strong potential to reduce smoking rates and improve individuals\u27 health

Proteomic Analyses of Host and Pathogen Responses during Bovine Mastitis

The pursuit of biomarkers for use as clinical screening tools, measures for early detection, disease monitoring, and as a means for assessing therapeutic responses has steadily evolved in human and veterinary medicine over the past two decades. Concurrently, advances in mass spectrometry have markedly expanded proteomic capabilities for biomarker discovery. While initial mass spectrometric biomarker discovery endeavors focused primarily on the detection of modulated proteins in human tissues and fluids, recent efforts have shifted to include proteomic analyses of biological samples from food animal species. Mastitis continues to garner attention in veterinary research due mainly to affiliated financial losses and food safety concerns over antimicrobial use, but also because there are only a limited number of efficacious mastitis treatment options. Accordingly, comparative proteomic analyses of bovine milk have emerged in recent years. Efforts to prevent agricultural-related food-borne illness have likewise fueled an interest in the proteomic evaluation of several prominent strains of bacteria, including common mastitis pathogens. The interest in establishing biomarkers of the host and pathogen responses during bovine mastitis stems largely from the need to better characterize mechanisms of the disease, to identify reliable biomarkers for use as measures of early detection and drug efficacy, and to uncover potentially novel targets for the development of alternative therapeutics. The following review focuses primarily on comparative proteomic analyses conducted on healthy versus mastitic bovine milk. However, a comparison of the host defense proteome of human and bovine milk and the proteomic analysis of common veterinary pathogens are likewise introduced

A novel two DOF control for train-like guidance of multiple articulated vehicles

This paper presents a novel two DOF control for train-like guidance of general multiple articulated vehicles with all wheel steering. The model based control scheme consists of a feedforward and a feedback part designed separately. Within the nonlinear feedforward part the steering angles are calculated that theoretically cause every single axle to follow a desired path exactly. Thus in the nonlinear feedback part only model uncertainties and disturbances have to be compensated. Simulations as well as road tests show that the designed control system allows train-like vehicle guidance while it is robust against varying road conditions, payload as well as velocity

Cancer Data Visualization: Developing Tools to Serve the Needs of Diverse Stakeholders

Purpose of review To describe how cancer data visualization tools can catalyze novel research and inform local cancer control planning. Recent findings In recent years, cancer centers across the nation have increasingly embraced geospatial tools to respond to the unique distributions of disease and multilevel risk factors within their catchment areas. Sylvester Comprehensive Cancer Center in Miami, Florida, recently developed a publicly available, interactive, web-based cancer data visualization tool called SCAN360. Using SCAN360 as an example, we discuss key considerations and challenges for the development of cancer data visualization tools that serve the needs of stakeholders in community, academic and government settings. Cancer data visualization tools are useful for stakeholders from diverse sectors and may facilitate a range of cancer control efforts, from identifying regions for targeted outreach and engagement, to informing the allocation of resources for government and community initiatives, and motivating collaborative, interdisciplinary cancer research

How Trust in Cancer Information Has Changed in the Era of COVID-19: Patterns by Race and Ethnicity

COVID-19 emerged during an era of heightened attention to systemic racism and the spread of misinformation. This context may have impacted public trust in health information about chronic diseases like cancer. Here, we examine data from the 2018 and 2020 Health Information National Trends Survey (N = 7,369) to describe how trust in cancer information from government health agencies, doctors, family and friends, charitable organizations, and religious organizations changed after COVID-19 became a pandemic, and whether that change varied by race/ethnicity. Statistical methods included chi-square tests and multiple logistic regression modeling. Overall, the proportion of respondents who reported a high degree of trust in cancer information from doctors increased (73.65% vs. 77.34%, p = .04). Trends for trust in information from government health agencies and family and friends varied significantly by race/ethnicity, with substantial declines observed among non-Hispanic Blacks (NHB) only. The odds of reporting a high degree of trust in cancer information from government health agencies and friends and family decreased by 53% (OR = 0.47, 95% CI = 0.24-0.93) and 73% (OR = 0.27, 95% CI = 0.09-0.82), respectively, among NHB, but were stable for other groups. Future studies should monitor whether recent declines in trust among NHB persist and unfavorably impact participation in preventive care

Abstract C056: Cancer patterns and trends in Costa Rica: A population-based tumor registry study

Abstract Background: Recent economic and social changes in low- and middle-income countries in Latin American have influenced the raise of noncommunicable diseases, including cancer. Data from cancer registries are critical for surveilling disease trends during periods of epidemiologic transition. The aim of this study is to generate population estimates of cancer incidence rates in Costa Rica and to evaluate geographical differences. Methods: The National Tumor Registry in Costa Rica was queried for cancer cases diagnosed between 2009-2014. Population data were used to calculate sex, country and region-specific age standardized rates (ASR) per 100,000 people using the World Health Organization's 2000 standard population. Standardized incidence ratios (SIR) and 95% confidence intervals (CI) were calculated to assess the effect of sex and geographic regions. Results: The overall cancer incidence rate in Costa Rica was 219.24 cases per 100,000. Females had a higher cancer rates relative to males (SIR: 1.1, 95% CI: 1.08-1.11, p < .001). The leading cancers were prostate (ASR: 53.09, 95% CI: 51.75-54.46), female breast (ASR: 48.73; 95% CI: 47.54-49.94), cervical (ASR: 30.78; 95% CI: 29.77-31.62), stomach (ASR: 17.45; 95% CI: 16.93-17.99), colorectal (ASR: 16.49; 95% CI: 15.98-17.00) and thyroid (ASR: 12.96; 95% CI: 12.54-13.40) cancers. San Jose had the highest breast and colon cancers rates whereas, Cartago had the highest rates for gastric and thyroid cancers. Conclusion: Costa Rica has a growing cancer burden involving preventable cancers. Continued monitoring of trends in incidence rates is needed to implement cancer control actions. Further involvement to create cancer prevention strategies and programs aimed to reduce cancer burden is warranted. Citation Format: Omar Picado, Jordan Baeker-Bispo, Layla Bouzoubaa, Raymond R. Balise, Gilberto Lopes, Erin N. Kobetz. Cancer patterns and trends in Costa Rica: A population-based tumor registry study [abstract]. In: Proceedings of the Eleventh AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2018 Nov 2-5; New Orleans, LA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl):Abstract nr C056

Variation in type II endometrial cancer risk by Hispanic subpopulation: An exploratory analysis

Minorities have demonstrated an increased risk for type II endometrial cancers, but no data exists about risk among minority subpopulations. Our objective was to evaluate heterogeneity in risk of type II endometrial cancer (EC) histologies across race and Hispanic sub-groups using data from Florida's statewide cancer registry (FCDS). FCDS contains data on N=26,416 women diagnosed with EC from 2004 to 2013. Our analysis included women ≥18years of age who were classified as non-Hispanic White (NHW), non-Hispanic Black (NHB) or belonged to one of five Hispanic sub-groups, and had a histology code consistent with type I or type II EC. Binary logistic regression analyses were performed to model risk of type II versus type I ECs across racial and ethnic groups relative to NHW. Relative to NHW, overall odds of being diagnosed with a type II EC were significantly higher in NHB (OR=2.64, 95%CI: 2.38–2.92), Cubans (OR=1.35, 95%CI: 1.08–1.68) and South and Central Americans (SCA) (OR=1.84, 95%CI: 1.40–2.43). Compared to NHW, odds of serous EC were significantly higher in Cubans (OR=2.15, 95% CI: 1.51–3.05) and NHB (OR=2.51, 95% CI: 2.11–2.97); odds of carcinosarcoma (CS) were significantly higher in NHB (OR=2.97, 95% CI: 2.47–3.57) and Puerto Ricans (OR=2.35, 95%CI: 1.32–4.17); and odds of grade III adenocarcinoma (AG3) were significantly higher in NHB (OR=1.60, 95% CI: 1.42–1.81) and SCA (OR=1.76, 95%CI: 1.29–2.40). Risk of type II EC varies considerably across Hispanic sub-groups, with Cubans, Puerto Ricans and SCA characterized by elevated odds for specific type II histologies. •Type II endometrial cancer disproportionally affects non-White women.•Hispanic subgroups display variable risks for type II endometrial histologies.•Cuban women have a significantly elevated odds of uterine serous carcinoma.•Risk of grade 3 endometrioid carcinoma is similar in Black and South American women